Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Frontiers in Oncology|February 16, 2023
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from IsraelItamar Averbuch, Saeed Salman, Noa Shtamper, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactionsGal Markel, Rachel Seidman, Noam Stern, et al.
Cancers|January 28, 2026
CT Body Composition Changes Predict Survival in Immunotherapy-Treated Cancer Patients: A Retrospective Cohort StudyShlomit Tamir, Hilla Vardi Behar, Ronen Tal, et al.
Molecular Cancer Therapeutics|April 3, 2012
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactionsRona Ortenberg, Yair Sapir, Lee Raz, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Cancer Immunology Research|June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma CellsNaama Margolis, Hanna Moalem, Tomer Meirson, et al.
International Immunology|June 7, 2005
The involvement of NK cells in ankylosing spondylitisNiva Azuz-Lieberman, Gal Markel, Sa'ar Mizrahi, et al.
Melanoma Research|December 18, 2018
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanomaBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Frontiers in Oncology|February 16, 2023
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from IsraelItamar Averbuch, Saeed Salman, Noa Shtamper, et al.
Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactionsGal Markel, Rachel Seidman, Noam Stern, et al.
Cancers|January 28, 2026
CT Body Composition Changes Predict Survival in Immunotherapy-Treated Cancer Patients: A Retrospective Cohort StudyShlomit Tamir, Hilla Vardi Behar, Ronen Tal, et al.
Molecular Cancer Therapeutics|April 3, 2012
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactionsRona Ortenberg, Yair Sapir, Lee Raz, et al.
Plos One|May 5, 2011
Regulation of cancer aggressive features in melanoma cells by microRNAsEyal Greenberg, Liat Hershkovitz, Orit Itzhaki, et al.
Cancer Immunology Research|June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma CellsNaama Margolis, Hanna Moalem, Tomer Meirson, et al.
International Immunology|June 7, 2005
The involvement of NK cells in ankylosing spondylitisNiva Azuz-Lieberman, Gal Markel, Sa'ar Mizrahi, et al.
Melanoma Research|December 18, 2018
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanomaBen Boursi, Thomas J Werner, Saeid Gholami, et al.
Pageof 14